Affinity Asset Advisors, LLC Ascendis Pharma A/S Transaction History

Affinity Asset Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$86.1 - $127.36 $2.27 Million - $3.36 Million	-26,400 Reduced 56.9%	20,000 $2.52 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $982,640 - $1.18 Million	-11,360 Reduced 19.67%	46,400 $4.34 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $1.24 Million - $1.74 Million	17,760 Added 44.4%	57,760 $5.16 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $3.25 Million - $3.93 Million	-30,997 Reduced 43.66%	40,000 $4.29 Million
Q4 2022 Feb 13, 2023	SELL	$99.42 - $131.97 $2.88 Million - $3.83 Million	-29,003 Reduced 29.0%	70,997 $8.67 Million
Q3 2022 Nov 14, 2022	SELL	$84.03 - $110.23 $2.11 Million - $2.77 Million	-25,087 Reduced 20.06%	100,000 $10.3 Million
Q2 2022 Aug 12, 2022	BUY	$78.08 - $117.61 $397,192 - $598,282	5,087 Added 4.24%	125,087 $11.6 Million
Q1 2022 May 13, 2022	BUY	$102.18 - $135.75 $12.3 Million - $16.3 Million	120,000 New	120,000 $14.1 Million
Q4 2021 Feb 11, 2022	SELL	$127.1 - $169.66 $4.56 Million - $6.09 Million	-35,910 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $1.79 Million - $2.81 Million	15,910 Added 79.55%	35,910 $5.72 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $1.25 Million - $1.73 Million	10,000 Added 100.0%	20,000 $2.58 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $1.51 Million - $1.83 Million	10,000 New	10,000 $1.67 Million

240

58.3M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $6.98B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.